Concepedia
Statistics
Publications
15
Citations
699
H-Index
14
Active since
2001
Affiliations
Vaccinex (United States)(Current)
University of Rochester
Johns Hopkins University
Cleveland Clinic Lerner College of Medicine
Johns Hopkins Medicine
Elizabeth E. Evans is an author at Vaccinex (United States) specializing in oncology, medicine, and tumor immunology.
Publications per year
2001–2022
SEMA4D compromises blood–brain barrier, activates microglia, and inhibits remyelination in neurodegenerative disease
Ernest Smith, Alan S. Jonason, Christine Reilly et al. · Neurobiology of Disease · 2014 · 118 citations · Full text
Life Sciences, Neurology, Neuroscience +17
Antibody Blockade of Semaphorin 4D Promotes Immune Infiltration into Tumor and Enhances Response to Other Immunomodulatory Therapies
Elizabeth E. Evans, Alan S. Jonason, Sebold Torno et al. · Cancer Immunology Research · 2015 · 108 citations · Full text
Medicine, Immunology, Oncology +17
A gene on the HER2 amplicon, C35, is an oncogene in breast cancer whose actions are prevented by inhibition of Syk
Elad Katz, Sylvie Dubois-Marshall, Andrew H. Sims et al. · British Journal of Cancer · 2010 · 74 citations · Full text
Medicine, Molecular Biology, Oncology +17
Semaphorin4D Inhibition Improves Response to Immune-Checkpoint Blockade via Attenuation of MDSC Recruitment and Function
Paúl E. Clavijo, Jay Friedman, Yvette Robbins et al. · Cancer Immunology Research · 2018 · 62 citations · Full text
Pepinemab antibody blockade of SEMA4D in early Huntington’s disease: a randomized, placebo-controlled, phase 2 trial
Andrew Feigin, Elizabeth E. Evans, Terrence L. Fisher et al. · Nature Medicine · 2022 · 62 citations · Full text
Medicine, Neurology, Pharmacology +13
1–5 of 15